Search

Search results

Medical Advisory Board

Our Medical Advisory Board (MAB) advises our Board of Trustees in order that they can approve grants for research projects.

jCyte update

In spring 2021, the US company jCyte announced detailed results from their successful phase 2b clinical trial of jCell, a stem cell-based treatment for RP.

Major innovation award

Retina UK invites expressions of interest to their first major innovation grant call, which will result in an award of up to £1million over five years as a strategic and targeted investment to result in transformative impact for therapy for inherited retinal dystrophy.